Akt/eNOS signaling and PLN S-sulfhydration are involved in H2S-dependent cardiac effects in frog and rat

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 4, 2013, Pages

  Mazza, Rosa ^a   Pasqua, Teresa ^a   Cerra, Maria Carmela ^a   Angelone, Tommaso ^a   Gattuso, Alfonsina ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Hydrogen sulfide; Inotropism; Lusitropism; Nitric oxide synthase cGMP PKG pathway

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; HYDROGEN SULFIDE; KT 5823; PROTEIN KINASE B; TRITON X 100;

ANIMAL EXPERIMENT; ANURA; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME PHOSPHORYLATION; HEART; HEART AFTERLOAD; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PRELOAD; HEART STROKE VOLUME; IMMUNOPRECIPITATION; INOTROPISM; INTRACELLULAR SIGNALING; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SULFHYDRATION; VASODILATATION; WESTERN BLOTTING;

EID: 84881631433     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00088.2013     Document Type: Article

References (57)

1. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. Abramochkin DV, Moiseenko LS, Kuzmin VS. The effect of hydrogen sulfide on electrical activity of rat atrial myocardium. Bull Exp Biol Med 147: 683-686, 2009.
3. Acierno R, Gattuso A, Guerrieri A, Mannarino C, Amelio D, Tota B. Nitric oxide modulates the frog heart ventricle morphodynamics. Comp Biochem Physiol A Mol Integr Physiol 151: 51-60, 2008.
4. Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, Moore PK. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 149: 625-634, 2006.
5. Angelone T, Quintieri AM, Brar BK, Limchiyawat PT, Tota B, Mahata SK, Cerra MC. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac ino-tropism and lusitropism. Endocrinology 149: 4780-4793, 2008.
6. Angelone T, Quintieri AM, Pasqua T, Gentile S, Tota B, Mahata SK, Cerra MC. Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the anti-hypertensive Catestatin. Am J Physiol Heart Circ Physiol 302: H431-H442, 2012.
7. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316: 670-678, 2006.
8. Brutsaert DL, Sys SU. Relaxation and diastole of the heart. Physiol Rev 69: 1228-1315, 1989.
9. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, Roviezzo F, Brancaleone V, Cirino G. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30: 1998-2004, 2010.
10. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Zaid A, Gianno-gonas P, Cantalupo A, Dhayade S, Karalis KP, Wang R, Feil R, Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Cirino G. cGMP-depen-dent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. PLos One 7: e53319. 2012.
11. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76: 29-40, 2007.
12. Cerra MC, Angelone T, Parisella ML, Pellegrino D, Tota B. Nitrite modulates contractility of teleost (Anguilla anguilla and Chionodraco hamatus, i.e, the Antarctic hemoglobinless icefish) and frog (Rana escu-lenta) hearts. Biochim Biophys Acta 1787: 849-855, 2009.
13. Cerra MC, Imbrogno S. Phospholamban and cardiac function: a comparative perspective in vertebrates. Acta Physiol (Oxf) 205: 9-25, 2012.
14. 2+ uptake via KATP channel and PI3K/Akt pathway. Life Sci 91: 271-278, 2012.
15. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Módis K, Pano-poulos P, Asimakopoulou A, Gerö D, Sharina I, Martin E, Szabo C. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA 109: 9161-9166, 2012.
16. Corti A, Mannarino C, Mazza R, Angelone T, Longhi R, Tota B. Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart. Gen Comp Endocrinol 136: 217-224, 2004.
17. Dimmeler S, Fleming I, Fisslthaler B, Hermann B, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
18. Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, Olson KR. Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 288: R243-R252, 2005.
19. Filice E, Angelone T, De Francesco EM, Pellegrino D, Maggiolini M, Cerra MC. Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17fj-estradiol in the male rat heart. Cell Physiol Biochem 28: 41-52, 2011.
20. Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem 113: 14-26, 2010.
21. Gattuso A, Mazza R, Pellegrino D, Tota B. Endocardial endothelium mediates luminal ACh-NO signaling in isolated frog heart. Am J Physiol Heart Circ Physiol 276: H633-H641, 1999.
22. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, Tang C. H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 313: 362-368, 2004.
23. + channels and myocardial preconditioning. Circ Res 84: 973-979, 1999.
24. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531, 1997.
25. Jaffrey SR, Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001: l1, 2001.
26. Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 232: 138-146, 2007.
27. Liu YH, Lu M, Hu LF, Wong PT, Webb GD, Bian JS. Hydrogen sulfide in the mammalian cardiovascular system. Antioxid Redox Signal 17: 141-185, 2012.
28. Mazza R, Angelone T, Pasqua T, Gattuso A. Physiological evidence for pj3-adrenoceptor in frog (Rana esculenta) heart. Gen Comp Endocr 169: 151-157, 2010.
29. Mazza R, Gattuso A, Mannarino C, Brar BK, Barbieri SF, Tota B, Mahata SK. Catestatin (chromogranin A344-364) is a novel cardiosup-pressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart. Am J Physiol Heart Circ Physiol 295: H113-H122, 2008.
30. McKean T, Rocklage A, Schneider RJ. Glibenclamide binding in vertebrate cardiac membranes. J Exp Biol 182: 275-281, 1993.
31. Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120: 888-896, 2009.
32. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, Snyder SH. H2S signals through protein S-Sulfhydration. Sci Signal 2: ra72, 2009.
33. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK, Wang R, Amzel LM, Berkowitz DE, Snyder SH. Hydrogen sulfide as endothelium-derived hyperpolariz-ing factor sulfhydrates potassium channels. Circ Res 109: 1259-68, 2011.
34. Noma A. ATP-regulated potassium channels in the heart. Nature 305: 147-148, 1983.
35. Olson KR, Whitfield NL. Hydrogen sulfide and oxygen sensing in the cardiovascular system. Antioxid Redox Signal 12: 1219-1234, 2010.
36. Olson KR, Healy M, Qin J, Skovgaard N, Vulesevic B, Duff DW, Whitfield NL, Yang G, Wang R, Perry SF. Hydrogen sulfide as an oxygen sensor in trout gill chemoreceptors. Am J Physiol Regul Integr Comp Physiol 295: R669-R680, 2008.
37. Olson KR. Vascular actions of hydrogen sulfide in non-mammalian vertebrates. Antioxid Redox Signal 7: 804-812, 2005.
38. Olson KR. Hydrogen sulfide and oxygen sensing: implications in cardiorespiratory control. J Exp Biol 211: 2727-34, 2008.
39. Pan TT, Neo KL, Hu LF, Yong QC, Bian JS. H2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am J Physiol Cell Physiol 294: C169-C177, 2008.
40. Predmore BL, Lefer DJ. Hydrogen sulfide-mediated myocardial pre- and post-conditioning. Expert Rev Clin Pharmacol 4: 83-96, 2011.
41. Predmore BL, Julian D, Cardounel AJ. Hydrogen sulfide increases nitric oxide production from endothelial cells by an Akt-dependent mechanism. Front Physiol 2: 104, 2011.
42. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 146: 623-626, 2009a.
43. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sul-fide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11: 703-714, 2009b.
44. Sitdikova GF, Khaertdinov NN, Zefirov AL. Role of calcium and potassium channels in effects of hydrogen sulfide on frog myocardial contractility. Bull Exp Biol Med 151: 163-166, 2011.
45. Stecyk JAW, Skovgaard N, Nilsson GE, Wang T. Vasoactivity of hydrogen sulfide in normoxic and anoxic turtles (Trachemys scripta). Am J Physiol Regul Integr Comp Physiol 298: R1225-R1239, 2010.
46. Sun YG, Cao YX, Wang WW, Ma SF, Yao T, Zhu YC. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 79: 632-641, 2008.
47. Sys SU, Pellegrino D, Mazza R, Gattuso A, Andries LJ, Tota B. Endocardial endothelium in the avascular heart of the frog: morphology and role of nitric oxide. J Exp Biol 200: 3109-3118, 1997.
48. Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C. Bench-to-bedside review: Hydrogen sulfide-the third gaseous transmitter: applications for critical care. Crit Care 13: 213, 2009.
49. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 6: 1792-1798, 2002.
50. Webb GD, Lim LH, Oh VM, Yeo SB, Cheong YP, Ali MY, El Oakley R, Lee CN, Wong PS, Caleb MG, Salto-Tellez M, Bhatia M, Chan ES, Taylor EA, Moore PK. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther 324: 876-882, 2008.
51. Whiteman M, Le Trionnaire S, Chopra M, Fox B, Whatmore J. Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools. Clin Sci (Lond) 121: 459-488, 2011.
52. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R. H2S as a physiologic vasorelax-ant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008.
53. Yong QC, Lee SW, Foo CS, Neo KL, Chen X, Bian JS. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol 295: H1330-H1340, 2008.
54. Yong QC, Pan TT, Hu LF, Bian JS. Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts. J Mol Cell Cardiol 44: 701-710, 2008b.
55. Zhang Z, Huang H, Liu P, Tang C, Wang J. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening KATP channels. Can J Physiol Pharmacol 85: 1248-1253, 2007.
56. Zhao W, Wang R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: H474-H480, 2002.
57. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: 6008-6016, 2001.